InsidersTradesSigma
Track the 药康生物 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). The latest transaction was filed on 4 August 2026 (Sale). Among the most active insiders: 粱娟. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
药康生物 is a publicly traded company on the Shanghai Stock Exchange, specializing in the biopharmaceutical sector. It focuses on the development and commercialization of innovative drugs.